Compared with SARS-CoV-1 or MERS, SARS-CoV-2 is much less virulent.

Prepare for the Introduction to Epidemiology and Concepts of Infectious Disease Test with detailed study materials and multiple-choice questions. Arm yourself with knowledge and insights to excel in infectious disease diagnostics.

Multiple Choice

Compared with SARS-CoV-1 or MERS, SARS-CoV-2 is much less virulent.

Explanation:
Virulence is about how harmful a pathogen is per infection—the likelihood of severe illness or death in an individual. SARS-CoV-2 generally causes less severe disease per infected person than SARS-CoV-1 or MERS, which had higher death rates and more frequent severe outcomes for those infected. Because of that lower per‑infection harm, the virus is considered less virulent. It makes up for this to some extent with much higher transmissibility, leading to a large total burden, but the intrinsic severity of disease in a typical infection is lower compared with the other two viruses. So the statement is true: on average, SARS-CoV-2 is less virulent, even though its spread can still cause substantial morbidity and mortality due to the sheer number of infections.

Virulence is about how harmful a pathogen is per infection—the likelihood of severe illness or death in an individual. SARS-CoV-2 generally causes less severe disease per infected person than SARS-CoV-1 or MERS, which had higher death rates and more frequent severe outcomes for those infected. Because of that lower per‑infection harm, the virus is considered less virulent. It makes up for this to some extent with much higher transmissibility, leading to a large total burden, but the intrinsic severity of disease in a typical infection is lower compared with the other two viruses. So the statement is true: on average, SARS-CoV-2 is less virulent, even though its spread can still cause substantial morbidity and mortality due to the sheer number of infections.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy